Evidence map›Paper›PMID 25230522›Full record

ArticleNatural product communications2014

Bioactive secondary metabolites from acid mine waste extremophiles.

Andrea A Stierle, Donald B Stierle

Open access · greenAbstract read
In one paragraph

Article in Natural product communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Peculiarities of meroterpenoids and their bioproduction.Applied microbiology and biotechnology · 2021
    Review
  6. Antibiotics from Extremophilic Micromycetes.Russian journal of bioorganic chemistry · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrea A Stierle
Donald B Stierle
University of Montana · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
MT INBRE RESEARCH COREP20RR016455 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI HELD, SUZANNE EILEEN · 2001 to 2011
$34.4M
THE ROLE OF PULMONARY SUBPOPULATIONS AND TH2 IMMUNITY IN BALB/C SILICOSIS MODELP20RR017670 · NCRR · UNIVERSITY OF MONTANA · PI SHEPHERD, DAVID C · 2002 to 2011
$22.0M
Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP20GM103546 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2012 to 2021
$19.2M
Core Laboratory for Neuromolecular ProductionP30NS055022 · NINDS · UNIVERSITY OF MONTANA · PI THOMPSON, CHARLES MARK · 2008 to 2013
$4.2M
Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer AR01CA139159 · NCI · UNIVERSITY OF MONTANA · PI STIERLE, ANDREA ANNE · 2009 to 2011
$631k
NCI NIH HHS 5 P30 CA008748-44NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA139159NCRR NIH HHS P20 RR016455NCRR NIH HHS P20 RR017670NIGMS NIH HHS P20 GM103546NIGMS NIH HHS P20GM103546NINDS NIH HHS 3P30NS055022NINDS NIH HHS 5P30NS055022NINDS NIH HHS P30 NS055022
6 · The paper itself

Abstract

The extremophilic microbes of the Berkeley Pit Lake are a valuable source of new and interesting secondary metabolites. It is of particular interest that these acidophilic microbes produce small molecule inhibitors of pathways associated with low pH and high Eh. These same small molecules also inhibit molecular pathways induced by reactive oxygen species (ROS) and inflammation in mammalian cells. Low pH is a hallmark of inflammation and high Eh is one of ROS, so the suitability of this collection as a source of bioactive metabolites is actually quite biorational. Compound isolation was guided by inhibition of caspase-1 and matrix metalloproteinase-3, and active compounds were sent to the National Cancer Institute-Developmental Therapeutics Program and Memorial Sloan Kettering Cancer center for evaluation as either antiproliferative or cytotoxic agents.

Indexed as

Industrial WasteMiningAscomycotaChaetomiumEnzyme InhibitorsHydrogen-Ion ConcentrationMolecular StructurePenicilliumReactive Oxygen SpeciesEnzyme InhibitorsIndustrial WasteReactive Oxygen Species

Identifiers

PMID25230522
PMCPMC5156321
OpenAlexW2412230498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.